Refael Elisha Cohen

authorize the FDA to grant a compassionate use exemption to Refael Elisha Cohen for Antineoplaston therapy.
The Cohen family, of Houston, TX, is facing a battle none of us should have to go through - aggressive brain cancer in their 6-year old son Refael Elisha. Having recently received the devastating news from their doctors that "there is nothing more we can do for him", the Cohens are turning to a last resort - Antineoplaston Therapy at the Burzyinski clinic. However, the FDA pulled their approval for this treatment in 2012 pending further clinical trials. We are told that the FDA is nearing approval to resume this treatment, but Refael Elisha does not have time to wait.
We are asking the FDA to grant this exemption so we can continue to fight for his life.